Gsk PLC 13F institutional holdings

Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.

NYSE
GSK plc reported 13 holdings worth $602.2M for the period ended June 30, 2026.
NYSE
GSK plc has filed its quarterly 13F holdings report, detailing its equity investments as of March 31, 2026.
NYSE
GSK plc filed its Form 13F-HR, revealing its equity holdings totaling approximately $799 million as of December 31, 2025, across 15 distinct positions.